Literature DB >> 3114885

Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator.

S Z Goldhaber, J E Markis, C M Kessler, M F Meyerovitz, D Kim, D E Vauchan, A P Selwyn, J Loscalzo, D L Dawley, G V Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3114885     DOI： 10.1055/s-2007-1003489

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  3 in total

Review 1.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

2.  Similarity in Presentation and Response to Thrombolysis Among Women and Men with Pulmonary Embolism.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

Review 3.  Is there an optimal "door to cath time" in the treatment of acute pulmonary embolism with catheter-directed thrombolysis?

Authors:  Aranyak Rawal; Devarshi Ardeshna; Kirstin Hesterberg; Brandon Cave; Uzoma N Ibebuogu; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2019-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.